Back to All Events

Talk: Creating consensus on a lexicon for cancer early detection and screening liquid biopsy tests

  • Precision Medicine Tri-Conference 1 Park Boulevard San Diego, CA, 92101 United States (map)

In this talk at the 2024 Precision Medicine Tri-Conference, BLOODPAC Executive Director Lauren C. Leiman will provide an overview of the Blood Profiling Atlas in Cancer (BLOODPAC)’s soon-to-be-published lexicon of key terms in MCED and single-cancer early detection, created through collaborative discussion involving major assay developers, pharmaceutical companies, academic institutions, and not-for-profits working in the cancer early detection space.

Previous
February 29

Panel Discussion: Creating Awareness Amongst Decision-Makers on Local & Global Disparities in Liquid Biopsy Research and Practice to Shape an Inclusive Future for Understudied Diseases
Next
March 28

Panel: Emerging Approaches to Clinical Validation of MCED Liquid Biopsy Tests